• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Philip W. Kantoff, MD

Professor, Department of Medicine, Harvard Medical School

Physician, Medicine, Brigham And Women's Hospital

Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Contact Info

Philip Kantoff
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA, 02215
Mailstop: Dana 1230
Phone: 617-632-1914
Fax: 617-632-2165
philip_kantoff@dfci.harvard.edu

Assistant

Renée Fox
Executive Assistant
Medical Oncology - STO-GU
Dana-Farber Cancer Institute
450 Brookline Ave
Boston, MA, 02215
Mailstop: DA-1230E
Phone: 617-632-1914
Fax: 617-632-2165
renee_fox@dfci.harvard.edu

DF/HCC Program Affiliation

Prostate Cancer, Leader

DF/HCC Associations

Member, Clinical Science Coordinating Committee
Principal Investigator, Prostate Cancer SPORE
Member, Center Scientific Council

Research Abstract

Our research team focuses on the molecular basis of genitourinary cancers and improved treatments for patients with prostate cancer, kidney cancer, bladder cancer, and testicular cancer. Laboratory research involves understanding the genetics of prostate cancer, while clinical research focuses on trials of novel therapeutics for genitourinary cancers.

In our laboratory, we have investigated germline, somatic genetic markers of prostate cancer behavior. We have identified germline markers of risk of prostate cancer, inherited variations that determine benefit from antioxidants, several mechanisms of resistance to androgen deprivation therapy including microRNAs and androgen transporters.
Our clinical trials have focused on:
- introducing novel therapeutics to patients with high-risk localized and metastatic prostate cancer including novel hormone therapies, chemotherapies and vaccines

Publications

View All Publications